The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

A charity event has raised more than £16,000 to fund research and support for people living with muscle-wasting conditions.

For the last five years, Maureen Smith, 86, from Nottingham has organised biannual charity lunches in her local community to ...

The Microscope Ball is the flagship fundraising event for Muscular Dystrophy UK and has raised almost £8 million for the charity to date. Cathey Cullum, Special Events Manager at Muscular Dystrophy UK ...

DUBLIN--(BUSINESS WIRE)--The "Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth ...

Living with a rare form of muscular dystrophy, and being honoured with having the youngest-ever seat on the board of trustees for the charity Muscular Dystrophy UK, means I represent many members of ...

"Sometimes there are no answers and solutions to things, but that's okay." Bohemia Media has released an official trailer for an indie documentary film titled A Space in Time, which is opening in the ...

Duchenne muscular dystrophy is a genetic muscle-wasting disease that almost always only affect boys. Around 2500 boys in the UK are affected and with no cure most patients do not live beyond their ...

A drug commonly used to treat leukemia is showing potential as a treatment that could slow the progression of the muscle-wasting condition, Duchenne muscular dystrophy. A drug commonly used to treat ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an innovation-focused biopharmaceutical company committed to developing new products for rare diseases, today shared updated results from its Phase 2 ...